SciTech Chronicles. . . . . . . . .Mar 1st, 2025

  Deeds will not be less valiant because they are unpraised. Vol II No 54 318 links Curated Children of primary school age demonstrate the h...

Alzheimer's therapy foralumab nasal spray cleared by FDA for...

Foralumab is an antibody being developed by Tiziana Life Sciences that's designed to block CD3, a protein on the surface of immune T-cells.

Alzheimer's News Today
#Foralumab monoclonal antibody might hold therapeutic potential for multiple human inflammatory diseases. https://www.pnas.org/doi/10.1073/pnas.2220272120